Continue to site >
Trending ETFs

First Trust Nasdaq Pharmaceuticals ETF

ETF
FTXH
Dividend policy
Active
Price as of:
$26.09 +0.02 +0.08%
primary theme
Health Care Sector Equity
FTXH (ETF)

First Trust Nasdaq Pharmaceuticals ETF

Dividend policy
Active
Price as of:
$26.09 +0.02 +0.08%
primary theme
Health Care Sector Equity
FTXH (ETF)

First Trust Nasdaq Pharmaceuticals ETF

Dividend policy
Active
Price as of:
$26.09 +0.02 +0.08%
primary theme
Health Care Sector Equity

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$26.09

$17.8 M

0.60%

$0.16

0.60%

Vitals

YTD Return

1.2%

1 yr return

7.6%

3 Yr Avg Return

3.7%

5 Yr Avg Return

6.3%

Net Assets

$17.8 M

Holdings in Top 10

59.7%

52 WEEK LOW AND HIGH

$25.8
$23.00
$27.00

Expenses

OPERATING FEES

Expense Ratio 0.60%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 83.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund

Investment Style

Health


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$26.09

$17.8 M

0.60%

$0.16

0.60%

FTXH - Profile

Distributions

  • YTD Total Return 1.2%
  • 3 Yr Annualized Total Return 3.7%
  • 5 Yr Annualized Total Return 6.3%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 1.07%
DIVIDENDS
  • Dividend Yield 0.6%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    First Trust Nasdaq Pharmaceuticals ETF
  • Fund Family Name
    First Trust
  • Inception Date
    Sep 20, 2016
  • Shares Outstanding
    700002
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Daniel Lindquist

Fund Description

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.


FTXH - Performance

Return Ranking - Trailing

Period FTXH Return Category Return Low Category Return High Rank in Category (%)
YTD 1.2% -80.3% 25.3% 79.44%
1 Yr 7.6% -28.4% 77.3% 93.47%
3 Yr 3.7%* -0.1% 33.4% 97.97%
5 Yr 6.3%* 2.1% 32.2% 95.10%
10 Yr N/A* 9.8% 21.9% N/A

* Annualized

Return Ranking - Calendar

Period FTXH Return Category Return Low Category Return High Rank in Category (%)
2020 10.6% -13.6% 178.2% 65.90%
2019 21.2% 3.8% 63.8% 48.28%
2018 -10.2% -49.7% 21.5% 72.26%
2017 16.7% -59.8% 54.4% 54.07%
2016 N/A -36.6% 11.6% N/A

Total Return Ranking - Trailing

Period FTXH Return Category Return Low Category Return High Rank in Category (%)
YTD 1.2% -80.6% 25.3% 79.44%
1 Yr 7.6% -30.4% 77.3% 90.54%
3 Yr 3.7%* -15.9% 33.4% 95.53%
5 Yr 6.3%* -7.4% 32.2% 93.68%
10 Yr N/A* 9.8% 21.9% N/A

* Annualized

Total Return Ranking - Calendar

Period FTXH Return Category Return Low Category Return High Rank in Category (%)
2020 10.6% -13.6% 178.2% 65.90%
2019 21.2% 3.8% 63.8% 48.28%
2018 -10.2% -25.3% 22.2% 73.72%
2017 16.7% -10.8% 54.4% 66.67%
2016 N/A -36.6% 11.6% N/A

FTXH - Holdings

Concentration Analysis

FTXH Category Low Category High FTXH % Rank
Net Assets 17.8 M 238 K 50.5 B 90.40%
Number of Holdings 29 11 477 91.14%
Net Assets in Top 10 10.7 M 2.18 K 21.1 B 65.82%
Weighting of Top 10 59.65% 8.6% 94.7% 5.91%

Top 10 Holdings

  1. Horizon Therapeutics PLC 11.12%
  2. Horizon Therapeutics PLC 11.12%
  3. Horizon Therapeutics PLC 11.12%
  4. Horizon Therapeutics PLC 11.12%
  5. Horizon Therapeutics PLC 11.12%
  6. Horizon Therapeutics PLC 11.12%
  7. Horizon Therapeutics PLC 11.12%
  8. Horizon Therapeutics PLC 11.12%
  9. Horizon Therapeutics PLC 11.12%
  10. Horizon Therapeutics PLC 11.12%

Asset Allocation

Weighting Return Low Return High FTXH % Rank
Stocks
99.80% 83.68% 101.79% 43.88%
Cash
0.20% -0.82% 10.99% 54.85%
Preferred Stocks
0.00% 0.00% 6.25% 50.21%
Other
0.00% -24.25% 7.97% 56.96%
Convertible Bonds
0.00% 0.00% 0.10% 45.99%
Bonds
0.00% 0.00% 15.36% 48.95%

Stock Sector Breakdown

Weighting Return Low Return High FTXH % Rank
Healthcare
100.00% 63.33% 100.00% 13.50%
Utilities
0.00% 0.00% 1.14% 33.33%
Technology
0.00% 0.00% 19.13% 38.82%
Real Estate
0.00% 0.00% 6.13% 37.13%
Industrials
0.00% 0.00% 7.02% 37.55%
Financial Services
0.00% 0.00% 1.92% 48.95%
Energy
0.00% 0.00% 0.80% 33.33%
Communication Services
0.00% 0.00% 7.81% 35.44%
Consumer Defense
0.00% 0.00% 28.21% 40.93%
Consumer Cyclical
0.00% 0.00% 16.95% 49.79%
Basic Materials
0.00% 0.00% 8.13% 61.18%

Stock Geographic Breakdown

Weighting Return Low Return High FTXH % Rank
US
99.80% 57.23% 100.70% 5.91%
Non US
0.00% 0.00% 42.77% 97.47%

FTXH - Expenses

Operational Fees

FTXH Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.60% 0.08% 2.91% 57.69%
Management Fee 0.60% 0.00% 1.25% 37.99%
12b-1 Fee 0.00% 0.00% 1.00% 11.39%
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

FTXH Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FTXH Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FTXH Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 83.00% 0.00% 256.00% 81.82%

FTXH - Distributions

Dividend Yield Analysis

FTXH Category Low Category High FTXH % Rank
Dividend Yield 0.60% 0.00% 2.44% 50.00%

Dividend Distribution Analysis

FTXH Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annually Monthly Monthly

Net Income Ratio Analysis

FTXH Category Low Category High FTXH % Rank
Net Income Ratio 1.07% -2.54% 1.92% 8.62%

Capital Gain Distribution Analysis

FTXH Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually

Dividend Payout History

View More +

FTXH - Fund Manager Analysis

Managers

Daniel Lindquist


Start Date

Tenure

Tenure Rank

Sep 20, 2016

5.03

5.0%

Daniel J. Lindquist, CFA, was born in 1970. Mr. Lindquist earned a B.A. in Business Economics from Wheaton College and has an MBA in Finance from the University of Chicago. He has been with First Trust Advisors L.P. since 2004 and is a Managing Director. Mr. Lindquist is the Chairman of the Investment Committee and is responsible for the overall supervision of the Separate Managed Accounts.

Jon Erickson


Start Date

Tenure

Tenure Rank

Sep 20, 2016

5.03

5.0%

Jon C. Erickson, CFA, was born in 1966. Mr. Erickson earned a B.S. in Computer Science from the University of Illinois and has an MBA from the University of Illinois in Finance. He has been with First Trust Advisors L.P. since 1994 and he is a Portfolio Manager and Senior Vice President. As the head of FTA’s Equity Research Group, Mr. Erickson shall be responsible for determining the securities to be purchased and sold by Funds that do not utilize quantitative investment strategies on behalf of the Investment Committee.

Chris Peterson


Start Date

Tenure

Tenure Rank

Sep 20, 2016

5.03

5.0%

Chris A. Peterson, CFA was born in 1975. Mr. Peterson earned a B.S in Finance from Bradley University and has an MBA from the University of Chicago Booth School of Business with concentrations in Analytic Finance & Accounting. He has been with First Trust Advisors L.P. since 2000. As head of FTA’s Portfolio Advisor’s Strategy Research Group, Mr. Peterson shall be responsible for developing and implementing quantitative equity strategies on behalf of the Investment Committee.

Roger Testin


Start Date

Tenure

Tenure Rank

Sep 20, 2016

5.03

5.0%

Roger F. Testin, CFA, was born in 1966. Mr. Testin earned a B.S. in Accounting from the University of Illinois and has an MBA in Finance from the University of Chicago. He has been with First Trust Advisors L.P. since 2001 and he is a Portfolio Manager and Senior Vice President. As Product Manager for the VA’s, SMA’s and International Managed Products, Mr. Testin shall be responsible for the daily implementation and execution of the strategies for these product vehicles on behalf of the Investment Committee.

David McGarel


Start Date

Tenure

Tenure Rank

Sep 20, 2016

5.03

5.0%

David G. McGarel, CFA, was born in 1966. Mr. McGarel earned a B.S. in Accounting from the University of Notre Dame. He has been with First Trust Advisors L.P. since 1997 and he is a Managing Director, Chief Operating Officer and the Chief Investment Officer. As head of FTA’s Strategy Research Group, Mr. McGarel shall be responsible for developing and implementing quantitative investment strategies for those Funds that have investment policies that require them to follow such strategies, on behalf of the Investment Committee.

Stan Ueland


Start Date

Tenure

Tenure Rank

Sep 20, 2016

5.03

5.0%

Mr. Ueland joined First Trust Advisors as a Vice President in August 2005 and has been a Senior Vice President of First Trust and FTP since September 2012. At First Trust, he plays an important role in executing the investment strategies of each portfolio of exchange-traded funds advised by First Trust. Before joining First Trust, he was vice president of sales at BondWave LLC from May 2004 through August 2005, an account executive for Mina Capital Management LLC and Samaritan Asset Management LLC from January 2003 through May 2004, and a sales consultant at Oracle Corporation from January 1997 through January 2003.

Erik Russo


Start Date

Tenure

Tenure Rank

Dec 31, 2020

0.75

0.8%

Mr. Russo is a Vice President of First Trust. He is responsible for implementing the investment strategies of each portfolio of exchange-traded funds advised by First Trust in his role as a Portfolio Manager. Mr. Russo joined First Trust in January of 2010.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.03 24.06 6.71 1.46